Home fairness benchmarks Nifty 50 and Sensex fell about half a per cent on Monday, as promoting strain in vitality and FMCG shares outweighed good points in IT shares. The Sensex misplaced 319.2 factors to finish at 77,186.7 whereas the Nifty 50 gave up 121.1 factors to settle at 23,361.1. Broader indices Nifty Midcap 100 and Nifty Smallcap 100 fell 0.9 per cent and a couple of.1 per cent respectively, sharply underperforming the headline gauges.
Buyers continued to trace incoming earnings knowledge because the outcomes season gathered steam on Dalal Road.
As the main focus shifts to a brand new buying and selling session, listed below are a lot of shares price monitoring on Tuesday:
Company Motion | Dividend and bonus shares
Aarti Medicine, Aurionpro Options, Emami, KPIT Tech, LT Meals, Orient Electrical and SRF shares are set to commerce ex-dividend on Tuesday.
Additionally on the opening bell itself, Redtape shares will commerce ex-bonus on February 4.
Company Outcomes | Titan, Tata Energy, Asian Paints…
Asian Paints, Tata Energy, Titan, Godrej Properties, JK Tyre and PC Jeweller are among the many corporations set to report their quarterly numbers on Tuesday.
Energy Grid
Energy Grid has repoted a 1.9 per cent decline in its internet revenue to Rs 3,894.1 crore for the quarter ended December 31, simply assembly analysts’ expectations.
Zee Enterprise analysts had pegged the state-run firm’s internet revenue at Rs 3,885 crore.
Tata Chemical substances
Tata Chemical substances has staged a weaker-than-expected monetary efficiency ofr the October-December interval.
Its consolidated loss stood at Rs 53 crore for the third quarter of the present monetary yr, as aginst a internet revenue of Rs 158 crore a yr in the past. Analysts pegged the Tata group chemical producer’s quarterly internet revenue at Rs 157 crore.
Gateway Distriparks
The corporate has registered a multi-fold bounce in its internet revenue to Rs 455 crore for the October-December interval, pushed by an distinctive gai of Rs 391 crore.
Its quarterly income has elevated about 2.5 per cent to Rs 403 crore, in response to a regulatory submitting.
Cipla
Drug maker Cipla has introduced an funding of Rs 426 crore in its subsidiary Cipla Medpro South Africa Proprietary (CMSA) by fairness.
Catch key highlights of Funds 2025 right here. For all different information, go to Zeebiz.com.
